Comparison of cytokine measurements using ELISA, ELISPOT and semi-quantitative RT-PCR

被引:92
作者
Favre, N
Bordmann, G
Rudin, W
机构
[1] Swiss Tropical Institute, Socinstrasse 57
关键词
RT-PCR; ELISPOT; ELISA; tumour necrosis factor alpha; interferon gamma; interleukin-4; experimental murine model;
D O I
10.1016/S0022-1759(97)00033-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We have investigated the correlation between results obtained by three different methods (semi-quantitative RT-PCR, ELISA and ELISPOT) used to measure cytokine expression by mouse leukocytes. The production of the cytokines tumour necrosis factor-alpha (TNF alpha), interferon-gamma (IFN gamma) and interleukin-4 (IL-4), was analysed with all three methods. In a simple experimental murine in vivo model of leukocyte stimulation, consisting of a single intravenous injection of anti-CD3 antibodies followed by a short incubation in vitro, the results obtained with spleen cells for each of the three cytokines differed greatly, depending on the method used. For TNF alpha, a significant increase in RNA was observed upon stimulation, whereas the number of spot-forming cells did not increase and the protein was not detectable in serum or in cell culture supernatants by ELISA. In vitro cultured splenocytes showed a strong correlation between all three methods for IFN alpha. Upon stimulation, the amount of RNA for IL-4 increased in parallel with the secretion of the cytokine and the number of spot-forming cells. However, high numbers of spot forming cells were observed in controls. We conclude that, depending on the specific aim of an investigation, combinations of different methods have to be chosen carefully in order to detect activation of leukocytes for cytokine expression.
引用
收藏
页码:57 / 66
页数:10
相关论文
共 30 条
  • [11] Differential spontaneous expression of mRNA for IL-4, IL-10, IL-13, IL-2 and interferon-gamma (IFN-gamma) in peripheral blood mononuclear cells (PBMC) from atopic patients
    Esnault, S
    Benbernou, N
    Lavaud, F
    Shin, HC
    Potron, G
    Guenounou, M
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 103 (01) : 111 - 118
  • [12] ESPEL E, 1996, EUR J IMMUNOL, V26, P1
  • [13] Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice
    Eugster, HP
    Muller, M
    Karrer, U
    Car, BD
    Schnyder, B
    Eng, VM
    Woerly, G
    LeHir, M
    diPadova, F
    Aguet, M
    Zinkernagel, R
    Bluethmann, H
    Ryffel, B
    [J]. INTERNATIONAL IMMUNOLOGY, 1996, 8 (01) : 23 - 36
  • [14] USE OF THE CTL44 CELL-LINE, A DERIVATIVE OF CTL/L CELLS, TO IDENTIFY AND QUANTIFY MOUSE INTERLEUKIN-4 BY BIOASSAY
    FAVRE, N
    ERB, P
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 164 (02) : 213 - 220
  • [15] Favre N, 1996, BIOTECHNIQUES, V21, P28
  • [16] QUANTITATIVE POLYMERASE CHAIN-REACTION WITH OLIGODEOXYNUCLEOTIDE LIGATION ASSAY/ENZYME-LINKED IMMUNOSORBENT-ASSAY DETECTION
    FRIEDHOFF, P
    HAHN, M
    WOLFES, H
    PINGOUD, A
    [J]. ANALYTICAL BIOCHEMISTRY, 1993, 215 (01) : 9 - 16
  • [17] THE TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR-NECROSIS-FACTOR RECEPTOR
    GRELL, M
    DOUNI, E
    WAJANT, H
    LOHDEN, M
    CLAUSS, M
    MAXEINER, B
    GEORGOPOULOS, S
    LESSLAUER, W
    KOLLIAS, G
    PFIZENMAIER, K
    SCHEURICH, P
    [J]. CELL, 1995, 83 (05) : 793 - 802
  • [18] ESTABLISHMENT OF MOUSE-CELL LINES WHICH CONSTITUTIVELY SECRETE LARGE QUANTITIES OF INTERLEUKIN-2, INTERLEUKIN-3, INTERLEUKIN-4 OR INTERLEUKIN-5, USING MODIFIED CDNA EXPRESSION VECTORS
    KARASUYAMA, H
    MELCHERS, F
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (01) : 97 - 104
  • [19] SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS CORRELATE WITH PARASITEMIA AND DISEASE SEVERITY IN HUMAN MALARIA
    KERN, P
    HEMMER, CJ
    GALLATI, H
    NEIFER, S
    KREMSNER, P
    DIETRICH, M
    PORZSOLT, F
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (04) : 930 - 934
  • [20] LOPEZCEPERO M, 1994, J IMMUNOL, V152, P3333